nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefpodoxime—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000738	0.000738	CcSEcCtD
Cefpodoxime—Dehydration—Doxorubicin—pancreatic cancer	0.000737	0.000737	CcSEcCtD
Cefpodoxime—Eosinophilia—Epirubicin—pancreatic cancer	0.000733	0.000733	CcSEcCtD
Cefpodoxime—Dry skin—Doxorubicin—pancreatic cancer	0.000726	0.000726	CcSEcCtD
Cefpodoxime—Dizziness—Sunitinib—pancreatic cancer	0.000725	0.000725	CcSEcCtD
Cefpodoxime—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000725	0.000725	CcSEcCtD
Cefpodoxime—Abdominal pain—Irinotecan—pancreatic cancer	0.000714	0.000714	CcSEcCtD
Cefpodoxime—Body temperature increased—Irinotecan—pancreatic cancer	0.000714	0.000714	CcSEcCtD
Cefpodoxime—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000713	0.000713	CcSEcCtD
Cefpodoxime—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000713	0.000713	CcSEcCtD
Cefpodoxime—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000712	0.000712	CcSEcCtD
Cefpodoxime—Bronchitis—Epirubicin—pancreatic cancer	0.000712	0.000712	CcSEcCtD
Cefpodoxime—Anaemia—Docetaxel—pancreatic cancer	0.000707	0.000707	CcSEcCtD
Cefpodoxime—Pancytopenia—Epirubicin—pancreatic cancer	0.000703	0.000703	CcSEcCtD
Cefpodoxime—Gastritis—Doxorubicin—pancreatic cancer	0.000701	0.000701	CcSEcCtD
Cefpodoxime—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000699	0.000699	CcSEcCtD
Cefpodoxime—Vomiting—Sunitinib—pancreatic cancer	0.000697	0.000697	CcSEcCtD
Cefpodoxime—Body temperature increased—Gemcitabine—pancreatic cancer	0.000695	0.000695	CcSEcCtD
Cefpodoxime—Dysuria—Epirubicin—pancreatic cancer	0.000692	0.000692	CcSEcCtD
Cefpodoxime—Neutropenia—Epirubicin—pancreatic cancer	0.000692	0.000692	CcSEcCtD
Cefpodoxime—Rash—Sunitinib—pancreatic cancer	0.000691	0.000691	CcSEcCtD
Cefpodoxime—Dermatitis—Sunitinib—pancreatic cancer	0.00069	0.00069	CcSEcCtD
Cefpodoxime—Abdominal distension—Doxorubicin—pancreatic cancer	0.000689	0.000689	CcSEcCtD
Cefpodoxime—Urticaria—Fluorouracil—pancreatic cancer	0.000687	0.000687	CcSEcCtD
Cefpodoxime—Headache—Sunitinib—pancreatic cancer	0.000686	0.000686	CcSEcCtD
Cefpodoxime—Syncope—Docetaxel—pancreatic cancer	0.000686	0.000686	CcSEcCtD
Cefpodoxime—Asthma—Doxorubicin—pancreatic cancer	0.000685	0.000685	CcSEcCtD
Cefpodoxime—Leukopenia—Docetaxel—pancreatic cancer	0.000684	0.000684	CcSEcCtD
Cefpodoxime—Pollakiuria—Epirubicin—pancreatic cancer	0.000684	0.000684	CcSEcCtD
Cefpodoxime—Body temperature increased—Fluorouracil—pancreatic cancer	0.000683	0.000683	CcSEcCtD
Cefpodoxime—Eosinophilia—Doxorubicin—pancreatic cancer	0.000678	0.000678	CcSEcCtD
Cefpodoxime—Palpitations—Docetaxel—pancreatic cancer	0.000676	0.000676	CcSEcCtD
Cefpodoxime—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000676	0.000676	CcSEcCtD
Cefpodoxime—Weight increased—Epirubicin—pancreatic cancer	0.000674	0.000674	CcSEcCtD
Cefpodoxime—Loss of consciousness—Docetaxel—pancreatic cancer	0.000672	0.000672	CcSEcCtD
Cefpodoxime—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000668	0.000668	CcSEcCtD
Cefpodoxime—Cough—Docetaxel—pancreatic cancer	0.000667	0.000667	CcSEcCtD
Cefpodoxime—Hypersensitivity—Irinotecan—pancreatic cancer	0.000665	0.000665	CcSEcCtD
Cefpodoxime—Pneumonia—Epirubicin—pancreatic cancer	0.000664	0.000664	CcSEcCtD
Cefpodoxime—Convulsion—Docetaxel—pancreatic cancer	0.000662	0.000662	CcSEcCtD
Cefpodoxime—Hypertension—Docetaxel—pancreatic cancer	0.00066	0.00066	CcSEcCtD
Cefpodoxime—Bronchitis—Doxorubicin—pancreatic cancer	0.000659	0.000659	CcSEcCtD
Cefpodoxime—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000654	0.000654	CcSEcCtD
Cefpodoxime—Myalgia—Docetaxel—pancreatic cancer	0.000651	0.000651	CcSEcCtD
Cefpodoxime—Chest pain—Docetaxel—pancreatic cancer	0.000651	0.000651	CcSEcCtD
Cefpodoxime—Nausea—Sunitinib—pancreatic cancer	0.000651	0.000651	CcSEcCtD
Cefpodoxime—Pancytopenia—Doxorubicin—pancreatic cancer	0.00065	0.00065	CcSEcCtD
Cefpodoxime—Renal failure—Epirubicin—pancreatic cancer	0.000649	0.000649	CcSEcCtD
Cefpodoxime—Asthenia—Irinotecan—pancreatic cancer	0.000648	0.000648	CcSEcCtD
Cefpodoxime—Stomatitis—Epirubicin—pancreatic cancer	0.000643	0.000643	CcSEcCtD
Cefpodoxime—Dysuria—Doxorubicin—pancreatic cancer	0.00064	0.00064	CcSEcCtD
Cefpodoxime—Neutropenia—Doxorubicin—pancreatic cancer	0.00064	0.00064	CcSEcCtD
Cefpodoxime—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000637	0.000637	CcSEcCtD
Cefpodoxime—Dry mouth—Docetaxel—pancreatic cancer	0.000637	0.000637	CcSEcCtD
Cefpodoxime—Pollakiuria—Doxorubicin—pancreatic cancer	0.000633	0.000633	CcSEcCtD
Cefpodoxime—Asthenia—Gemcitabine—pancreatic cancer	0.000631	0.000631	CcSEcCtD
Cefpodoxime—Haematuria—Epirubicin—pancreatic cancer	0.000629	0.000629	CcSEcCtD
Cefpodoxime—Confusional state—Docetaxel—pancreatic cancer	0.000629	0.000629	CcSEcCtD
Cefpodoxime—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000625	0.000625	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000624	0.000624	CcSEcCtD
Cefpodoxime—Weight increased—Doxorubicin—pancreatic cancer	0.000623	0.000623	CcSEcCtD
Cefpodoxime—Epistaxis—Epirubicin—pancreatic cancer	0.000622	0.000622	CcSEcCtD
Cefpodoxime—Pruritus—Gemcitabine—pancreatic cancer	0.000622	0.000622	CcSEcCtD
Cefpodoxime—Sinusitis—Epirubicin—pancreatic cancer	0.000619	0.000619	CcSEcCtD
Cefpodoxime—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000618	0.000618	CcSEcCtD
Cefpodoxime—Diarrhoea—Irinotecan—pancreatic cancer	0.000618	0.000618	CcSEcCtD
Cefpodoxime—Agranulocytosis—Epirubicin—pancreatic cancer	0.000616	0.000616	CcSEcCtD
Cefpodoxime—Pneumonia—Doxorubicin—pancreatic cancer	0.000614	0.000614	CcSEcCtD
Cefpodoxime—Shock—Docetaxel—pancreatic cancer	0.000614	0.000614	CcSEcCtD
Cefpodoxime—Pruritus—Fluorouracil—pancreatic cancer	0.000612	0.000612	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000611	0.000611	CcSEcCtD
Cefpodoxime—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000605	0.000605	CcSEcCtD
Cefpodoxime—Diarrhoea—Gemcitabine—pancreatic cancer	0.000602	0.000602	CcSEcCtD
Cefpodoxime—Renal failure—Doxorubicin—pancreatic cancer	0.0006	0.0006	CcSEcCtD
Cefpodoxime—Dizziness—Irinotecan—pancreatic cancer	0.000597	0.000597	CcSEcCtD
Cefpodoxime—Haemoglobin—Epirubicin—pancreatic cancer	0.000595	0.000595	CcSEcCtD
Cefpodoxime—Stomatitis—Doxorubicin—pancreatic cancer	0.000595	0.000595	CcSEcCtD
Cefpodoxime—Anorexia—Docetaxel—pancreatic cancer	0.000595	0.000595	CcSEcCtD
Cefpodoxime—Rhinitis—Epirubicin—pancreatic cancer	0.000594	0.000594	CcSEcCtD
Cefpodoxime—Haemorrhage—Epirubicin—pancreatic cancer	0.000592	0.000592	CcSEcCtD
Cefpodoxime—Diarrhoea—Fluorouracil—pancreatic cancer	0.000591	0.000591	CcSEcCtD
Cefpodoxime—Oedema peripheral—Epirubicin—pancreatic cancer	0.000584	0.000584	CcSEcCtD
Cefpodoxime—Hypotension—Docetaxel—pancreatic cancer	0.000583	0.000583	CcSEcCtD
Cefpodoxime—Haematuria—Doxorubicin—pancreatic cancer	0.000582	0.000582	CcSEcCtD
Cefpodoxime—Epistaxis—Doxorubicin—pancreatic cancer	0.000576	0.000576	CcSEcCtD
Cefpodoxime—Vomiting—Irinotecan—pancreatic cancer	0.000574	0.000574	CcSEcCtD
Cefpodoxime—Sinusitis—Doxorubicin—pancreatic cancer	0.000573	0.000573	CcSEcCtD
Cefpodoxime—Dizziness—Fluorouracil—pancreatic cancer	0.000572	0.000572	CcSEcCtD
Cefpodoxime—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00057	0.00057	CcSEcCtD
Cefpodoxime—Rash—Irinotecan—pancreatic cancer	0.000569	0.000569	CcSEcCtD
Cefpodoxime—Dermatitis—Irinotecan—pancreatic cancer	0.000569	0.000569	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000568	0.000568	CcSEcCtD
Cefpodoxime—Headache—Irinotecan—pancreatic cancer	0.000565	0.000565	CcSEcCtD
Cefpodoxime—Insomnia—Docetaxel—pancreatic cancer	0.000564	0.000564	CcSEcCtD
Cefpodoxime—Paraesthesia—Docetaxel—pancreatic cancer	0.00056	0.00056	CcSEcCtD
Cefpodoxime—Erythema multiforme—Epirubicin—pancreatic cancer	0.00056	0.00056	CcSEcCtD
Cefpodoxime—Vomiting—Gemcitabine—pancreatic cancer	0.000559	0.000559	CcSEcCtD
Cefpodoxime—Dyspnoea—Docetaxel—pancreatic cancer	0.000556	0.000556	CcSEcCtD
Cefpodoxime—Somnolence—Docetaxel—pancreatic cancer	0.000555	0.000555	CcSEcCtD
Cefpodoxime—Rash—Gemcitabine—pancreatic cancer	0.000554	0.000554	CcSEcCtD
Cefpodoxime—Dermatitis—Gemcitabine—pancreatic cancer	0.000554	0.000554	CcSEcCtD
Cefpodoxime—Tinnitus—Epirubicin—pancreatic cancer	0.000552	0.000552	CcSEcCtD
Cefpodoxime—Haemoglobin—Doxorubicin—pancreatic cancer	0.000551	0.000551	CcSEcCtD
Cefpodoxime—Headache—Gemcitabine—pancreatic cancer	0.000551	0.000551	CcSEcCtD
Cefpodoxime—Vomiting—Fluorouracil—pancreatic cancer	0.00055	0.00055	CcSEcCtD
Cefpodoxime—Rhinitis—Doxorubicin—pancreatic cancer	0.000549	0.000549	CcSEcCtD
Cefpodoxime—Dyspepsia—Docetaxel—pancreatic cancer	0.000549	0.000549	CcSEcCtD
Cefpodoxime—Haemorrhage—Doxorubicin—pancreatic cancer	0.000548	0.000548	CcSEcCtD
Cefpodoxime—Rash—Fluorouracil—pancreatic cancer	0.000545	0.000545	CcSEcCtD
Cefpodoxime—Dermatitis—Fluorouracil—pancreatic cancer	0.000545	0.000545	CcSEcCtD
Cefpodoxime—Decreased appetite—Docetaxel—pancreatic cancer	0.000542	0.000542	CcSEcCtD
Cefpodoxime—Headache—Fluorouracil—pancreatic cancer	0.000542	0.000542	CcSEcCtD
Cefpodoxime—Oedema peripheral—Doxorubicin—pancreatic cancer	0.00054	0.00054	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000539	0.000539	CcSEcCtD
Cefpodoxime—Fatigue—Docetaxel—pancreatic cancer	0.000538	0.000538	CcSEcCtD
Cefpodoxime—Nausea—Irinotecan—pancreatic cancer	0.000536	0.000536	CcSEcCtD
Cefpodoxime—Constipation—Docetaxel—pancreatic cancer	0.000534	0.000534	CcSEcCtD
Cefpodoxime—Pain—Docetaxel—pancreatic cancer	0.000534	0.000534	CcSEcCtD
Cefpodoxime—Chills—Epirubicin—pancreatic cancer	0.000532	0.000532	CcSEcCtD
Cefpodoxime—Alopecia—Epirubicin—pancreatic cancer	0.000523	0.000523	CcSEcCtD
Cefpodoxime—Nausea—Gemcitabine—pancreatic cancer	0.000522	0.000522	CcSEcCtD
Cefpodoxime—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000518	0.000518	CcSEcCtD
Cefpodoxime—Feeling abnormal—Docetaxel—pancreatic cancer	0.000514	0.000514	CcSEcCtD
Cefpodoxime—Nausea—Fluorouracil—pancreatic cancer	0.000513	0.000513	CcSEcCtD
Cefpodoxime—Tinnitus—Doxorubicin—pancreatic cancer	0.000511	0.000511	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00051	0.00051	CcSEcCtD
Cefpodoxime—Flatulence—Epirubicin—pancreatic cancer	0.000508	0.000508	CcSEcCtD
Cefpodoxime—Tension—Epirubicin—pancreatic cancer	0.000506	0.000506	CcSEcCtD
Cefpodoxime—Dysgeusia—Epirubicin—pancreatic cancer	0.000505	0.000505	CcSEcCtD
Cefpodoxime—Nervousness—Epirubicin—pancreatic cancer	0.000501	0.000501	CcSEcCtD
Cefpodoxime—Back pain—Epirubicin—pancreatic cancer	0.000499	0.000499	CcSEcCtD
Cefpodoxime—Abdominal pain—Docetaxel—pancreatic cancer	0.000493	0.000493	CcSEcCtD
Cefpodoxime—Body temperature increased—Docetaxel—pancreatic cancer	0.000493	0.000493	CcSEcCtD
Cefpodoxime—Chills—Doxorubicin—pancreatic cancer	0.000492	0.000492	CcSEcCtD
Cefpodoxime—Alopecia—Doxorubicin—pancreatic cancer	0.000484	0.000484	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000478	0.000478	CcSEcCtD
Cefpodoxime—Anaemia—Epirubicin—pancreatic cancer	0.000477	0.000477	CcSEcCtD
Cefpodoxime—Agitation—Epirubicin—pancreatic cancer	0.000474	0.000474	CcSEcCtD
Cefpodoxime—Flatulence—Doxorubicin—pancreatic cancer	0.00047	0.00047	CcSEcCtD
Cefpodoxime—Tension—Doxorubicin—pancreatic cancer	0.000468	0.000468	CcSEcCtD
Cefpodoxime—Dysgeusia—Doxorubicin—pancreatic cancer	0.000467	0.000467	CcSEcCtD
Cefpodoxime—Malaise—Epirubicin—pancreatic cancer	0.000465	0.000465	CcSEcCtD
Cefpodoxime—Nervousness—Doxorubicin—pancreatic cancer	0.000463	0.000463	CcSEcCtD
Cefpodoxime—Vertigo—Epirubicin—pancreatic cancer	0.000463	0.000463	CcSEcCtD
Cefpodoxime—Syncope—Epirubicin—pancreatic cancer	0.000462	0.000462	CcSEcCtD
Cefpodoxime—Leukopenia—Epirubicin—pancreatic cancer	0.000462	0.000462	CcSEcCtD
Cefpodoxime—Back pain—Doxorubicin—pancreatic cancer	0.000462	0.000462	CcSEcCtD
Cefpodoxime—Hypersensitivity—Docetaxel—pancreatic cancer	0.00046	0.00046	CcSEcCtD
Cefpodoxime—Palpitations—Epirubicin—pancreatic cancer	0.000456	0.000456	CcSEcCtD
Cefpodoxime—Loss of consciousness—Epirubicin—pancreatic cancer	0.000453	0.000453	CcSEcCtD
Cefpodoxime—Cough—Epirubicin—pancreatic cancer	0.00045	0.00045	CcSEcCtD
Cefpodoxime—Asthenia—Docetaxel—pancreatic cancer	0.000448	0.000448	CcSEcCtD
Cefpodoxime—Convulsion—Epirubicin—pancreatic cancer	0.000447	0.000447	CcSEcCtD
Cefpodoxime—Hypertension—Epirubicin—pancreatic cancer	0.000445	0.000445	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000443	0.000443	CcSEcCtD
Cefpodoxime—Pruritus—Docetaxel—pancreatic cancer	0.000441	0.000441	CcSEcCtD
Cefpodoxime—Anaemia—Doxorubicin—pancreatic cancer	0.000441	0.000441	CcSEcCtD
Cefpodoxime—Chest pain—Epirubicin—pancreatic cancer	0.000439	0.000439	CcSEcCtD
Cefpodoxime—Myalgia—Epirubicin—pancreatic cancer	0.000439	0.000439	CcSEcCtD
Cefpodoxime—Agitation—Doxorubicin—pancreatic cancer	0.000438	0.000438	CcSEcCtD
Cefpodoxime—Anxiety—Epirubicin—pancreatic cancer	0.000438	0.000438	CcSEcCtD
Cefpodoxime—Discomfort—Epirubicin—pancreatic cancer	0.000434	0.000434	CcSEcCtD
Cefpodoxime—Malaise—Doxorubicin—pancreatic cancer	0.00043	0.00043	CcSEcCtD
Cefpodoxime—Dry mouth—Epirubicin—pancreatic cancer	0.000429	0.000429	CcSEcCtD
Cefpodoxime—Vertigo—Doxorubicin—pancreatic cancer	0.000429	0.000429	CcSEcCtD
Cefpodoxime—Syncope—Doxorubicin—pancreatic cancer	0.000428	0.000428	CcSEcCtD
Cefpodoxime—Leukopenia—Doxorubicin—pancreatic cancer	0.000427	0.000427	CcSEcCtD
Cefpodoxime—Diarrhoea—Docetaxel—pancreatic cancer	0.000427	0.000427	CcSEcCtD
Cefpodoxime—Confusional state—Epirubicin—pancreatic cancer	0.000424	0.000424	CcSEcCtD
Cefpodoxime—Palpitations—Doxorubicin—pancreatic cancer	0.000422	0.000422	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000421	0.000421	CcSEcCtD
Cefpodoxime—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000419	0.000419	CcSEcCtD
Cefpodoxime—Cough—Doxorubicin—pancreatic cancer	0.000416	0.000416	CcSEcCtD
Cefpodoxime—Shock—Epirubicin—pancreatic cancer	0.000414	0.000414	CcSEcCtD
Cefpodoxime—Convulsion—Doxorubicin—pancreatic cancer	0.000413	0.000413	CcSEcCtD
Cefpodoxime—Dizziness—Docetaxel—pancreatic cancer	0.000413	0.000413	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000412	0.000412	CcSEcCtD
Cefpodoxime—Hypertension—Doxorubicin—pancreatic cancer	0.000412	0.000412	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000407	0.000407	CcSEcCtD
Cefpodoxime—Chest pain—Doxorubicin—pancreatic cancer	0.000406	0.000406	CcSEcCtD
Cefpodoxime—Myalgia—Doxorubicin—pancreatic cancer	0.000406	0.000406	CcSEcCtD
Cefpodoxime—Anxiety—Doxorubicin—pancreatic cancer	0.000405	0.000405	CcSEcCtD
Cefpodoxime—Discomfort—Doxorubicin—pancreatic cancer	0.000401	0.000401	CcSEcCtD
Cefpodoxime—Anorexia—Epirubicin—pancreatic cancer	0.000401	0.000401	CcSEcCtD
Cefpodoxime—Dry mouth—Doxorubicin—pancreatic cancer	0.000397	0.000397	CcSEcCtD
Cefpodoxime—Vomiting—Docetaxel—pancreatic cancer	0.000397	0.000397	CcSEcCtD
Cefpodoxime—Rash—Docetaxel—pancreatic cancer	0.000393	0.000393	CcSEcCtD
Cefpodoxime—Hypotension—Epirubicin—pancreatic cancer	0.000393	0.000393	CcSEcCtD
Cefpodoxime—Dermatitis—Docetaxel—pancreatic cancer	0.000393	0.000393	CcSEcCtD
Cefpodoxime—Confusional state—Doxorubicin—pancreatic cancer	0.000393	0.000393	CcSEcCtD
Cefpodoxime—Headache—Docetaxel—pancreatic cancer	0.000391	0.000391	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000389	0.000389	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000383	0.000383	CcSEcCtD
Cefpodoxime—Shock—Doxorubicin—pancreatic cancer	0.000383	0.000383	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000381	0.000381	CcSEcCtD
Cefpodoxime—Insomnia—Epirubicin—pancreatic cancer	0.000381	0.000381	CcSEcCtD
Cefpodoxime—Paraesthesia—Epirubicin—pancreatic cancer	0.000378	0.000378	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000376	0.000376	CcSEcCtD
Cefpodoxime—Dyspnoea—Epirubicin—pancreatic cancer	0.000375	0.000375	CcSEcCtD
Cefpodoxime—Somnolence—Epirubicin—pancreatic cancer	0.000374	0.000374	CcSEcCtD
Cefpodoxime—Anorexia—Doxorubicin—pancreatic cancer	0.000371	0.000371	CcSEcCtD
Cefpodoxime—Nausea—Docetaxel—pancreatic cancer	0.000371	0.000371	CcSEcCtD
Cefpodoxime—Dyspepsia—Epirubicin—pancreatic cancer	0.00037	0.00037	CcSEcCtD
Cefpodoxime—Decreased appetite—Epirubicin—pancreatic cancer	0.000366	0.000366	CcSEcCtD
Cefpodoxime—Hypotension—Doxorubicin—pancreatic cancer	0.000364	0.000364	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000363	0.000363	CcSEcCtD
Cefpodoxime—Fatigue—Epirubicin—pancreatic cancer	0.000363	0.000363	CcSEcCtD
Cefpodoxime—Pain—Epirubicin—pancreatic cancer	0.00036	0.00036	CcSEcCtD
Cefpodoxime—Constipation—Epirubicin—pancreatic cancer	0.00036	0.00036	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000355	0.000355	CcSEcCtD
Cefpodoxime—Insomnia—Doxorubicin—pancreatic cancer	0.000352	0.000352	CcSEcCtD
Cefpodoxime—Paraesthesia—Doxorubicin—pancreatic cancer	0.00035	0.00035	CcSEcCtD
Cefpodoxime—Dyspnoea—Doxorubicin—pancreatic cancer	0.000347	0.000347	CcSEcCtD
Cefpodoxime—Feeling abnormal—Epirubicin—pancreatic cancer	0.000347	0.000347	CcSEcCtD
Cefpodoxime—Somnolence—Doxorubicin—pancreatic cancer	0.000346	0.000346	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000344	0.000344	CcSEcCtD
Cefpodoxime—Dyspepsia—Doxorubicin—pancreatic cancer	0.000343	0.000343	CcSEcCtD
Cefpodoxime—Decreased appetite—Doxorubicin—pancreatic cancer	0.000339	0.000339	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000336	0.000336	CcSEcCtD
Cefpodoxime—Fatigue—Doxorubicin—pancreatic cancer	0.000336	0.000336	CcSEcCtD
Cefpodoxime—Urticaria—Epirubicin—pancreatic cancer	0.000334	0.000334	CcSEcCtD
Cefpodoxime—Constipation—Doxorubicin—pancreatic cancer	0.000333	0.000333	CcSEcCtD
Cefpodoxime—Pain—Doxorubicin—pancreatic cancer	0.000333	0.000333	CcSEcCtD
Cefpodoxime—Abdominal pain—Epirubicin—pancreatic cancer	0.000333	0.000333	CcSEcCtD
Cefpodoxime—Body temperature increased—Epirubicin—pancreatic cancer	0.000333	0.000333	CcSEcCtD
Cefpodoxime—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000321	0.000321	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000318	0.000318	CcSEcCtD
Cefpodoxime—Hypersensitivity—Epirubicin—pancreatic cancer	0.00031	0.00031	CcSEcCtD
Cefpodoxime—Urticaria—Doxorubicin—pancreatic cancer	0.000309	0.000309	CcSEcCtD
Cefpodoxime—Body temperature increased—Doxorubicin—pancreatic cancer	0.000308	0.000308	CcSEcCtD
Cefpodoxime—Abdominal pain—Doxorubicin—pancreatic cancer	0.000308	0.000308	CcSEcCtD
Cefpodoxime—Asthenia—Epirubicin—pancreatic cancer	0.000302	0.000302	CcSEcCtD
Cefpodoxime—Pruritus—Epirubicin—pancreatic cancer	0.000298	0.000298	CcSEcCtD
Cefpodoxime—Diarrhoea—Epirubicin—pancreatic cancer	0.000288	0.000288	CcSEcCtD
Cefpodoxime—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000287	0.000287	CcSEcCtD
Cefpodoxime—Asthenia—Doxorubicin—pancreatic cancer	0.000279	0.000279	CcSEcCtD
Cefpodoxime—Dizziness—Epirubicin—pancreatic cancer	0.000278	0.000278	CcSEcCtD
Cefpodoxime—Pruritus—Doxorubicin—pancreatic cancer	0.000276	0.000276	CcSEcCtD
Cefpodoxime—Vomiting—Epirubicin—pancreatic cancer	0.000268	0.000268	CcSEcCtD
Cefpodoxime—Diarrhoea—Doxorubicin—pancreatic cancer	0.000266	0.000266	CcSEcCtD
Cefpodoxime—Rash—Epirubicin—pancreatic cancer	0.000265	0.000265	CcSEcCtD
Cefpodoxime—Dermatitis—Epirubicin—pancreatic cancer	0.000265	0.000265	CcSEcCtD
Cefpodoxime—Headache—Epirubicin—pancreatic cancer	0.000264	0.000264	CcSEcCtD
Cefpodoxime—Dizziness—Doxorubicin—pancreatic cancer	0.000258	0.000258	CcSEcCtD
Cefpodoxime—Nausea—Epirubicin—pancreatic cancer	0.00025	0.00025	CcSEcCtD
Cefpodoxime—Vomiting—Doxorubicin—pancreatic cancer	0.000248	0.000248	CcSEcCtD
Cefpodoxime—Rash—Doxorubicin—pancreatic cancer	0.000246	0.000246	CcSEcCtD
Cefpodoxime—Dermatitis—Doxorubicin—pancreatic cancer	0.000245	0.000245	CcSEcCtD
Cefpodoxime—Headache—Doxorubicin—pancreatic cancer	0.000244	0.000244	CcSEcCtD
Cefpodoxime—Nausea—Doxorubicin—pancreatic cancer	0.000231	0.000231	CcSEcCtD
